SCHEMBL20127684

SCHEMBL20127684

c1ccc2c(c1)oc1c2cc(-c2c3ccccc3c(-c3ccc(-c4ccc5c6ccccc6c6ccccc6c5c4)cc3)c3ccccc23)c2oc3ccccc3c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.37
PLA2G4A P47712 5/20 0.37
ALOX5 P09917 2/20 0.37
AHR P35869 2/20 0.36
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP3A4 P08684 1/20 0.35
ALPI P09923 1/20 0.35
PKM P14618 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127672 0.95 ALOX5 (0.39) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL20127698 0.92 PLA2G2A (0.40) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL20127690 0.92 PLA2G2A (0.40) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL10122232 0.92 ALOX5 (0.40) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL10122243 0.89 AHR (0.41) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL20131263 0.88 PLA2G2A (0.33) PLA2G2APLA2G4AALOX5KDM4EGAA
SCHEMBL10122616 0.88 ALOX5 (0.41) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL20127421 0.88 ALOX5 (0.43) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL21249194 0.87 ALOX5 (0.39) PLA2G2APLA2G4AALOX5AHRKDM4E
SCHEMBL10122257 0.87 GPR84 (0.36) PLA2G2APLA2G4AALOX5AHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 PLA2G2A 2960/4885PLA2G4A 3780/4885ALOX5 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.